These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4152643)

  • 1. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
    Boissier JR; Coutte R; Advenier C; Giudicelli JF
    Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
    Cheymol G; Mouillé P; Laubie M; Schmitt H
    C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
    Takeda K; Iizuka H; Imai S
    Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta adrenolytic and hemodynamic effects of dl (hydroxy 2't-butylamino 3' propyloxy) 8-thiochromane (S 2395)].
    Laubie M; Schmitt H; Mouillé P; Cheymol G; Gilbert JC
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):334-46. PubMed ID: 4146789
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of a sodium lactate perfusion on the hemodynamic effects of beta-blockaders].
    Scebat A; Castan L; Renais R; Chiche J; Fernandez F; Gerbaux A
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):306-13. PubMed ID: 25055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dl-propranolol on atrial and ventricular rates in unanesthetized atrioventricular blocked dogs.
    Reynolds RD; DiSalvo J
    J Pharmacol Exp Ther; 1978 May; 205(2):374-81. PubMed ID: 25336
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
    Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
    [No Abstract]   [Full Text] [Related]  

  • 11. Nutritional circulation in the heart. 3. Effect of isoproterenol and beta adrenergic blockade on myocardial hemodynamics and rubicium-86 extraction in the isolated supported heart preparation.
    Somani P; Laddu AR; Hardm HF
    J Pharmacol Exp Ther; 1970 Dec; 175(3):577-92. PubMed ID: 4395225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical pharmacology of the beta-adrenolytic activity of pindolol].
    Hugues FC; Julien D; Munera Y; Heams D; Marche J
    Therapie; 1976; 31(2):179-93. PubMed ID: 7858
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.
    Jaillon P; Hecklé J; Weissenburger J; Cheymol G
    J Pharmacol Exp Ther; 1980 Feb; 212(2):347-53. PubMed ID: 6101348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative action of adrenergic beta-blockers on cardiac automatism and auriculoventricular conduction in the nonanesthetized dog].
    Duchêne-Marullaz P; Boucher M; Delaigue R; Kantelip JP; Gueorguev G
    Nouv Presse Med; 1978 Sep; 7(31):2689-96. PubMed ID: 30944
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pindolol in pediatrics. Evaluation of cardiac haemodinamics (author's transl)].
    Antoncecchi E; Mollica N; Ranieri L; Tagliente MR; Antoncecchi E
    Pediatr Med Chir; 1981; 3(6):551-4. PubMed ID: 6123984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Review of the cardiovascular pharmacology of perhexiline.
    Hudak WJ; Lewis RE; Lucas RW; Kuhn WL
    Postgrad Med J; 1973 Apr; 49():Suppl 3:16-25. PubMed ID: 4202743
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.